<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: Abbott Laboratories threaten the right to life</title>
	<atom:link href="http://www.stopaidssocieties.org.uk/2007/03/abbott-laboratories-threaten-the-right-to-life/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.stopaidssocieties.org.uk/2007/03/abbott-laboratories-threaten-the-right-to-life/</link>
	<description>A national network of student societies across the UK, who form the Student Stop AIDS Campaign</description>
	<pubDate>Thu, 29 Jul 2010 22:02:08 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.5.1</generator>
		<item>
		<title>By: Student Stop AIDS Societies &#187; Blog Archive &#187; The UK government now explicitly support Thailand in using the TRIPS flexibilities to gain access to life saving drugs! Campaigning works!!!</title>
		<link>http://www.stopaidssocieties.org.uk/2007/03/abbott-laboratories-threaten-the-right-to-life/#comment-902</link>
		<dc:creator>Student Stop AIDS Societies &#187; Blog Archive &#187; The UK government now explicitly support Thailand in using the TRIPS flexibilities to gain access to life saving drugs! Campaigning works!!!</dc:creator>
		<pubDate>Thu, 24 May 2007 11:44:48 +0000</pubDate>
		<guid isPermaLink="false">http://www.freecharity.org.uk/~stopaids/2007/03/abbott-laboratories-threaten-the-right-to-life/#comment-902</guid>
		<description>[...] In 29th January this year the challenge was made real as the government of Thailand issued a compulsory license under the TRIPS flexibilities to produce generic copies of Kaletra- a new 2nd line ARV patented by Abbott Laboratories. Thailand was facing a situation where increasing numbers of patients on anti-retroviral treatment needed to be moved onto second line drugs, but the government could not afford to pay the high prices charged for these drugs. (To read the full story click here) [...]</description>
		<content:encoded><![CDATA[<p>[...] In 29th January this year the challenge was made real as the government of Thailand issued a compulsory license under the TRIPS flexibilities to produce generic copies of Kaletra- a new 2nd line ARV patented by Abbott Laboratories. Thailand was facing a situation where increasing numbers of patients on anti-retroviral treatment needed to be moved onto second line drugs, but the government could not afford to pay the high prices charged for these drugs. (To read the full story click here) [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Katy</title>
		<link>http://www.stopaidssocieties.org.uk/2007/03/abbott-laboratories-threaten-the-right-to-life/#comment-900</link>
		<dc:creator>Katy</dc:creator>
		<pubDate>Tue, 01 May 2007 08:28:31 +0000</pubDate>
		<guid isPermaLink="false">http://www.freecharity.org.uk/~stopaids/2007/03/abbott-laboratories-threaten-the-right-to-life/#comment-900</guid>
		<description>The BBC published this story on 26th April. Visit the link below to read more:

http://news.bbc.co.uk/1/hi/world/asia-pacific/6587379.stm

A very good account...</description>
		<content:encoded><![CDATA[<p>The BBC published this story on 26th April. Visit the link below to read more:</p>
<p><a href="http://news.bbc.co.uk/1/hi/world/asia-pacific/6587379.stm" rel="nofollow">http://news.bbc.co.uk/1/hi/world/asia-pacific/6587379.stm</a></p>
<p>A very good account&#8230;</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Alissa- Oxford</title>
		<link>http://www.stopaidssocieties.org.uk/2007/03/abbott-laboratories-threaten-the-right-to-life/#comment-893</link>
		<dc:creator>Alissa- Oxford</dc:creator>
		<pubDate>Wed, 11 Apr 2007 16:02:56 +0000</pubDate>
		<guid isPermaLink="false">http://www.freecharity.org.uk/~stopaids/2007/03/abbott-laboratories-threaten-the-right-to-life/#comment-893</guid>
		<description>Hi all,

I just read that Abbott has offered to reduce the cost of Kaletra in Thailand and 40+ other low- and middle-income countries by more than half the current price, down to about $1,000 per patient per year!  The company has said that it will continue its plan not to introduce those 6 other new drugs in the country (thereby continuing to sanction Thailand for its use of the TRIPS flexibilities) but still this must be a step in the right direction....

Read a short article about these recent, unexpected developments at http://www.kaisernetwork.org/daily_reports/rep_index.cfm?DR_ID=44162/.</description>
		<content:encoded><![CDATA[<p>Hi all,</p>
<p>I just read that Abbott has offered to reduce the cost of Kaletra in Thailand and 40+ other low- and middle-income countries by more than half the current price, down to about $1,000 per patient per year!  The company has said that it will continue its plan not to introduce those 6 other new drugs in the country (thereby continuing to sanction Thailand for its use of the TRIPS flexibilities) but still this must be a step in the right direction&#8230;.</p>
<p>Read a short article about these recent, unexpected developments at <a href="http://www.kaisernetwork.org/daily_reports/rep_index.cfm?DR_ID=44162/" rel="nofollow">http://www.kaisernetwork.org/daily_reports/rep_index.cfm?DR_ID=44162/</a>.</p>
]]></content:encoded>
	</item>
</channel>
</rss>
